Currently, there are 109.26M common shares owned by the public and among those 107.73M shares have been available to trade.
Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 2 of these insider trades were purchases, accounting for 376,606 shares. Insider sales of the common stock occurred on 20 occasions, with total insider shares sold totaling 262,050 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 7.88, down -8.54%. The company’s stock has a 5-day price change of -9.09% and -39.10% over the past three months. MDRX shares are trading -27.55% year to date (YTD), with the 12-month market performance down to -54.90% lower. It has a 12-month low price of $7.89 and touched a high of $16.99 over the same period. MDRX has an average intraday trading volume of 1.97 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -12.27%, -19.17%, and -36.03% respectively.
Institutional ownership of Veradigm Inc (NASDAQ: MDRX) shares accounts for 104.83% of the company’s 109.26M shares outstanding.
It has a market capitalization of $830.38M and a beta (3y monthly) value of 0.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.68% over the week and 4.60% over the month.
Analysts forecast that Veradigm Inc (MDRX) will achieve an EPS of $0.3 for the current quarter, $0.29 for the next quarter and $0.88 for 2023. The lowest estimate earnings-per-share for the quarter is $0.23 while analysts give the company a high EPS estimate of $0.39. Comparatively, EPS for the current quarter was $0.79 a year ago. Earnings per share for the fiscal year are expected to increase by 2.10%, and -4.57% over the next financial year.
Looking at the support for the MDRX, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on January 03, 2024, with the firm’s price target at $11. Stephens was of a view on April 12, 2023 that the stock is Equal-Weight, while Piper Sandler gave the stock Neutral rating on February 01, 2023, issuing a price target of $17- $18.50. Argus on their part issued Buy rating on December 07, 2022.
